A Study to Evaluate the Safety and Tolerability of SKF-105517-D in Patients With Chronic Heart Failure - An Open-Label Study to Evaluate the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SKF-105517-D in Patients With Chronic Heart Failure (Phase I/II Study).

Trial Profile

A Study to Evaluate the Safety and Tolerability of SKF-105517-D in Patients With Chronic Heart Failure - An Open-Label Study to Evaluate the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SKF-105517-D in Patients With Chronic Heart Failure (Phase I/II Study).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Chronic heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Jan 2012 Results published in the Circulation Journal.
    • 04 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Nov 2009 Actual patient number (41) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top